AVE 33.3% 0.2¢ avecho biotechnology limited

its alive , page-20

  1. 5,798 Posts.
    lightbulb Created with Sketch. 737
    What a great way to end the year.
    My hope was that the price would hold ground, so this 4 year high is so very encouraging, considering the amount of news due in the short term. We now have a perfect launching platform for 2012.

    - Personal Care deal.
    - Anti-mastitis deal
    - anti-acne trial completion with commercial arrangement to follow.
    - anti-psoriasis was to enter phase 1 trial in this quarter.
    - Elixia expansion
    - completion of pharmacokinetic study on oxypatch.
    - animal insulin up to dosing stage.
    - high end hair care products due early 2012
    - etc etc etc

    And this could all conceivably occur in the next 3 months. No wonder people are now taking their positions and holding even more tightly.

    I'm also expecting the usual surprises to occur at a more rapid rate in 2012.
    How many products will be pipeline hold by year end 2012.

    And the price - easily another 75% price rise, but I won't say what I really think.

    Thoroughly enjoyed the year with all fellow pohsters. Thanks to all pohsters and readers and may we be celebrating together in the not to distant future.
    Happy new year.

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $13.22K 5.508M

Buyers (Bids)

No. Vol. Price($)
16 13199771 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 41616983 28
View Market Depth
Last trade - 16.10pm 04/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.